Inhibitors of monoamine oxidase B:pharmacology and clinical use in neurodegenerative disorders
Saved in:
Group Author: | ; |
---|---|
Published: |
Birkhäuser,
|
Publisher Address: | Basel Boston |
Publication Dates: | c1993. |
Literature type: | Book |
Language: | English |
Series: |
Milestones in drug therapy |
Subjects: | |
Carrier Form: | xviii, 360 p.: ill. ; 24 cm. |
ISBN: |
3764327820 (alk. paper) 0817627820 (alk. paper) |
Index Number: | R971 |
CLC: | R971 |
Call Number: | R971/I55/ |
Contents: |
Includes bibliographical references and index. Anatomy of the human basal ganglia / H. Braak and E. Braak -- Pathophysiological basis of Parkinson's Disease / M. Gerlach and P. Riederer -- Parkinson's Disease and its existing therapy / P.-A. Fischer -- Medicinal chemistry of present and future MAO-B inhibitors / J. Gaal and I. Hermecz -- l-deprenyl: a unique MAO-B inhibitor / E.E. Polymeropoulos -- Pharmacology of monoamine oxidase type B inhibitors / K. Magyar -- Pharmacological basis of the therapeutic effect of (-)-deprenyl in age-related neurological diseases / J. Knoll -- Neurotoxins and monoamine oxidase B inhibitors: possible mechanisms for the neuroprotective effect of (-)-deprenyl / V. Glover and M. Sandler -- Mode of action of MAO-B inhibitors / M. Gerlach, P. Riederer and M.B.H. Youdim -- Pharmacokinetics and clinical pharmacology of selegiline / E.H. Heinomen, M.I. Antila and R.A.S. Lammintausta -- Preclinical evaluation of l-deprenyl: lack of amphetamine-like abuse potential / S. Yasar ... [et al.]. (cont) History of l-deprenyl / M.J. Parnham -- MAO-B inhibitors in neurological disorders with special reference to selegiline / K. Wessel -- (-)-deprenyl combined with L-dopa in the treatment of Parkinson's Disease / T.S. Elizan -- Neuroprotective effects of MAO-B inhibition: clinical studies in Parkinson's Disease / P.A. LeWitt -- Alzheimer's Disease and l-deprenyl: rationales and findings / P.N. Tariot ... [et al.] -- Do MAO-B inhibitors have any role in the treatment of depression? / G. Laux -- Therapeutic place and value of present and future MAO-B inhibitors: l-deprenyl as the gold standard / P. Riederer and M.B.H. Youdim -- Chemical structures and pharmacological features of MAO-B inhibitors / W. Paul and I. Szelenyi -- Explanation of the nomenclature for optical isomers / E.E. Polymeropoulos. |